Experience. Commitment. Results.
We are investigating the Board of Directors of Black Ridge Acquisition Corp. (NasdaqCM: BRAC) related to the sale of Black Ridge to Allied Esports International, Inc. and affiliates. Under the terms of the proposed transaction, Black Ridge will issue to the former owners of Allied Esports and WPT Enterprises, Inc. (i) an aggregate of 11,602,754 … Read more
We are investigating Vital Therapies, Inc. (NasdaqGS: VTL) and its Board of Directors for potential federal law violations and/or breaches of fiduciary duties in connection with the acquisition of Immunic AG for approximately 735 shares of Vital Therapies common stock for each share of Immunic.
We are investigating the Board of Directors of Flex Pharma, Inc. (NasdaqCM: FLKS) related to the sale of the company to Salarius Pharmaceuticals, LLC. Under the terms of the proposed transaction, FLKS stockholders will own 19.9% of the combined company upon completion of the transaction.
We are investigating Travelport Worldwide LTD (TVPT) regarding its sale to affiliates of Siris Capital Group, LLC (“Siris”) and Evergreen Coast Capital Corp. (“Evergreen”) in an all-cash transaction valued at approximately $4.4 billion. Evergreen is the private equity affiliate of Elliott Management Corporation (“Elliott”).
We are investigating Asterias Biotherapeutics, Inc. (AST) regarding its sale to BioTIme, Inc. for 0.71 shares in BioTime for every share in Asterias.
We are investigating HomeTown Bankshares Corporation (HMTA) regarding its sale to American National Bankshares Inc. for 0.4150 shares of American National common stock for each share of HomeTown common stock held immediately prior to the Merger.
We are investigating OurPet’s Company (OPCO) regarding its sale to Hyper Pet LLC for $1.00 per share.
We are investigating Versum Materials, Inc. (VSM) for its sale to Entegris, Inc. for 1.120 shares of Entegris for each share of Versum.
We are investigating UQM Technologies, Inc. (UQM) for its sale to Danfoss Power Solutions for $1.71 per share.
We are investigating TCF Financial Corporation (TCF) for its sale to Chemical Financial Corporation for 0.5081 shares in Chemical for each TCF Financial share.